| Powder: | Yes |
|---|---|
| Customized: | Non-Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Children, Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name | Factory Provide Powder Febuxostat CAS 144060-53-7 |
| Appearance | White powder |
| Molecular formula | C16H16N2O3S |
| Molecular weight | 316.37 |
| Keywords | Powder Febuxostat,Price Febuxostat; Pure Febuxostat |
| Shelf Life | 24 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
What is Febuxostat?
Febuxostat, a selective xanthine oxidase inhibitor, was launched for the chronic management of hyperuricemia in patients with gout. Hyperuricemia is defined as a serum uric acid concentration exceeding the limit of solubility. It predisposes affected persons to gout, a disease characterized by the formation of crystals of monosodium urate or uric acid from supersaturated fluids in joints and other tissues. Crystal deposition is asymptomatic, but it is revealed by bouts of joint inflammation. If left untreated, further crystals accumulate in joints and can form deposits known as tophi. A major aim in gout management is the long-term reduction of serum uric acid concentrations below saturation levels, as this results in crystal dissolution and eventual disappearance.
Function of Febuxostat?
Febuxostat (INN; trade names Adenuric [EU], Febutaz [India] and Uloric [US]) is a urate lowering drug, an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and chronic gout.
Febuxostat reduces the production of uric acid in your body. Uric acid buildup can lead to gout or kidney stones.
Febuxostat is used to treat gout.
Febuxosta ,is a anti-gout Pharmaceutical Raw Materials.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}